Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thermo Fisher Scientific announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel.
read more
Tuesday, February 15, 2022
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. ...
read more
The PPD clinical research business of Thermo Fisher Scientific Inc. announced the creation of the PPD DCT Network to support global investigators and research sites participating in decentralized clinical trials (DCTs) for pharmaceutical and biotech ...
read more
Wednesday, February 14, 2024
The PPD clinical research business of Thermo Fisher Scientific Inc., is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
read more
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced the expansion of its central laboratory operations in Kentucky dedicated to accelerating pharmaceutical and biotech customers’ ...
read more
Tuesday, September 18, 2018
Thermo Fisher Scientific has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio.
read more
Monday, November 02, 2020
A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates.
read more
Wednesday, October 11, 2023
Thermo Fisher Scientific announced it has expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.
read more
The PPD clinical research business of Thermo Fisher Scientific Inc., unveiled a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
read more
Thermo Fisher Scientific has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the Asia-Pacific market.
read more
The PPD clinical research business of Thermo Fisher Scientific Inc. and Matrix Clinical Trials are collaborating to bring clinical trials to patients with a decentralized clinical trial (DCT) solution.
read more
Friday, September 06, 2019
Thermo Fisher Scientific has elected Debora Spar to its board of directors.
read more
Wednesday, August 30, 2017
Thermo Fisher Scientific has completed its acquisition of Patheon for approximately $7.2 billion.
read more
Thermo Fisher Scientific announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform.
read more
Wednesday, September 08, 2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and ...
read more